Geode Capital Management, LLC Curis Inc Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.57 - $0.99 $2,265 - $3,934
3,974 Added 0.48%
828,342 $687,000
Q1 2023

May 15, 2023
BUY
$0.51 - $0.78 $5,666 - $8,666
11,111 Added 1.37%
824,368 $494,000
Q4 2022

Feb 13, 2023
BUY
$0.47 - $17.22 $7,249 - $265,618
15,425 Added 1.93%
813,257 $447,000
Q3 2022

Nov 14, 2022
BUY
$0.74 - $15.01 $1,333 - $27,048
1,802 Added 0.23%
797,832 $558,000
Q2 2022

Aug 12, 2022
SELL
$0.71 - $2.43 $385,956 - $1.32 Million
-543,601 Reduced 40.58%
796,030 $783,000
Q1 2022

May 13, 2022
SELL
$2.31 - $5.13 $389,964 - $866,026
-168,816 Reduced 11.19%
1,339,631 $3.19 Million
Q4 2021

Feb 11, 2022
BUY
$4.45 - $8.09 $158,326 - $287,834
35,579 Added 2.42%
1,508,447 $7.18 Million
Q3 2021

Nov 12, 2021
BUY
$6.94 - $8.85 $654,039 - $834,041
94,242 Added 6.84%
1,472,868 $11.5 Million
Q2 2021

Aug 13, 2021
BUY
$7.45 - $16.27 $5.31 Million - $11.6 Million
712,270 Added 106.89%
1,378,626 $11.1 Million
Q1 2021

May 12, 2021
BUY
$8.78 - $12.8 $2.02 Million - $2.95 Million
230,543 Added 52.9%
666,356 $7.54 Million
Q4 2020

Feb 12, 2021
BUY
$1.08 - $8.2 $190,159 - $1.44 Million
176,074 Added 67.79%
435,813 $3.57 Million
Q1 2020

May 14, 2020
SELL
$0.67 - $1.85 $3,837 - $10,596
-5,728 Reduced 2.16%
259,739 $182,000
Q4 2019

Feb 13, 2020
BUY
$1.36 - $2.44 $3,443 - $6,178
2,532 Added 0.96%
265,467 $451,000
Q2 2019

Aug 14, 2019
BUY
$1.36 - $2.35 $60,937 - $105,296
44,807 Added 20.54%
262,935 $489,000
Q1 2019

May 14, 2019
SELL
$0.78 - $2.01 $526 - $1,356
-675 Reduced 0.31%
218,128 $434,000
Q4 2018

Feb 13, 2019
BUY
$0.62 - $2.25 $24,049 - $87,275
38,789 Added 21.55%
218,803 $150,000
Q3 2018

Nov 13, 2018
SELL
$1.38 - $1.94 $407 - $572
-295 Reduced 0.16%
180,014 $320,000
Q2 2018

Aug 14, 2018
BUY
$1.73 - $3.35 $311,934 - $604,035
180,309 New
180,309 $311,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email